Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02137720 · ClinicalTrials.gov registry record · NA
Translating Telephonic Diabetes Self-management Support to Primary Care Practice
A NA study, sponsored by Albert Einstein College of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 812
- Enrollment target
NCT02137720: Completed NA study, sponsored by Albert Einstein College of Medicine.
NCT02137720 is a NA study that has completed, run by Albert Einstein College of Medicine. The registered enrollment target is 812 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (42% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02137720, a NA study, has completed, sponsored by Albert Einstein College of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 812 participants
- Enrollment target
Study Summary
The goal of this study is to evaluate the implementation and effectiveness of an intervention to improve diabetes self-management, emotional distress and metabolic control among adults with type 2 diabetes receiving care in primary care practices throughout New York City. The program will be implemented by the New York City Department of Health, through their Primary Care Improvement Project.
Primary Outcome
Obtained from electronic medical record.
Interventions
- BEHAVIORAL Telephonic Diabetes Self-Management Support
- OTHER Educational Print Materials
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 812 participants |
| Start Date | 2014-06 |
| Est. Completion | 2019-09-20 |
| Phase | NA |
What the finished NCT02137720 record still lists
NCT02137720 is an interventional study that assigns participants to a tested intervention. The registered 812 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (42% lower).
The record links to 0 conditions, and to 2 interventions - of which Telephonic Diabetes Self-Management Support is the first listed.
NCT02137720 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02137720 about?
NCT02137720 is a clinical study titled "Translating Telephonic Diabetes Self-management Support to Primary Care Practice". The goal of this study is to evaluate the implementation and effectiveness of an intervention to improve diabetes self-management, emotional distress and metabolic control among adults with type 2 diabetes receiving care in primary care practices throughout New York City. The program will be impleme...
What is the current status of trial NCT02137720?
This trial is currently completed. It is a NA study. The enrollment target is 812 participants. The study started on 2014-06. Estimated completion is 2019-09-20.
What interventions are being tested in trial NCT02137720?
The interventions under investigation include: Telephonic Diabetes Self-Management Support (BEHAVIORAL), Educational Print Materials (OTHER).
Who is sponsoring clinical trial NCT02137720?
This trial is sponsored by Albert Einstein College of Medicine, which has 175 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02137720's enrollment target sits among peer trials
812 134th of 2000 higher than 1,867 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05519085 · 810 participants · Phase 3
A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)
- NCT07218029 · 815 participants · Phase 3
A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-038)
- NCT06529094 · 808 participants · NA
Implementing a Decision Support Tool to Prevent Community-Acquired Pressure Injury in Spinal Cord Injury (SCI) in the Spinal Cord Injury Clinic
- NCT04846959 · 818 participants
Study to Evaluate Pregnancy Outcomes in Risankizumab Exposed Pregnancies Relative to Those Non-risankizumab Exposed Pregnancies in Women With FDA Approved Indications
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia